[ad_1]
The EU will soon close a contract with the US company Pfizer and the German company Biontech (BioNTech) for the purchase of up to 300 million doses of its vaccine against the new coronavirus, which is now under development and testing, the European Commission announced today . .
In September, the EU reached an interim agreement with the companies.
EU Health Commissioner Stella Kyriakidis welcomed the encouraging news from the two labs that their vaccine in development is 90 percent effective against Covid-19.
Meanwhile, in Britain, Prime Minister Boris Johnson said it was too early to rely on a Covid-19 vaccine as a solution to the coronavirus pandemic, Reuters reported.
Britain’s Deputy Health Inspector Jonathan Van-Tam said a Covid-19 vaccine could be ready by Christmas, after Pfizer announced that its vaccine was 90 percent effective. It has been tested in 43,500 people in six countries and no negative side effects are mentioned.
Both companies plan to request emergency approval and use of the vaccine by the end of the month.
